CAM
JAZZ icon

Claret Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Claret Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$405K Hold
2,140
– – 0.05% 132
2025
Q4 		$364K Sell
2,140
-5
-0.2% -$767 0.04% 143
2025
Q3 		$283K Sell
2,145
-30
-1% -$3.6K 0.03% 174
2025
Q2 		$231K Buy
2,175
+418
+24% +$45.4K 0.03% 383
2025
Q1 		$218K Buy
1,757
+1
+0.1% +$130 0.03% 244
2024
Q4 		$216K Buy
+1,756
New +$207K 0.03% 248
2019
Q4 		– Sell
-1,617
Closed -$207K – 206
2019
Q3 		$207K Buy
+1,617
New +$217K 0.04% 177

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Claret Asset Management's JAZZ Position: Q1 2026 in Review

Claret Asset Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 2,140 shares worth $405K. The position accounts for 0.05% of the portfolio, ranked #132.

Claret Asset Management first reported a position in JAZZ in Q3 2019 and has held it in 7 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Claret Asset Management held 2,140 shares of Jazz Pharmaceuticals worth $405K as of Q1 2026.
  • Claret Asset Management left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
  • Jazz Pharmaceuticals made up 0.05% of Claret Asset Management's portfolio in Q1 2026, its #132 holding.
  • Claret Asset Management first reported a position in Jazz Pharmaceuticals in Q3 2019 and has held it in 7 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Claret Asset Management's 13F filing for Q1 2026, filed 11 May 2026.